Potential drugs to correct abnormal lipid metabolism related to NAFLD and NASH include acetyl-CoA carboxylase (ACC) inhibitors, stearoyl-CoA desaturase-1 (SCD1) inhibitors, fatty acid synthase (FASN) inhibitors, and so on. Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.